Comparability of self-reported medication use and pharmacy claims data

1. Gama H, Correia S, Lunet N. Questionnaire design and the recall of pharmacological treatments: a systematic review. Pharmacoepidemiology and Drug Safety 2009; (3): 175-87.

2. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. Journal of the American Geriatrics Society 1991; 39(11): 1079-84.

3. Klungel OH, de Boer A, Paes AH, et al. Influence of question structure on the recall of self-reported drug use. Journal of Clinical Epidemiology 2000; 53(3): 273-7.

4. Boudreau DM, Daling JR, Malone KE, et al. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. American Journal of Epidemiology 2004; 159(3): 308-17.

5. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. American Journal of Epidemiology 1982; 116(1): 114-22.

6. Boudreau DM, Doescher MP, Saver BG, et al. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status. Pharmacoepidemiology and Drug Safety 2005; 14(12): 877-84.

7. Pit S, Byles J. Older Australians' medication use: self-report by phone showed good agreement and accuracy compared with home visit. Journal of Clinical Epidemiology 2010; 63(4): 428-34.

8. Pit SW, Byles JE, Cockburn J. Accuracy of telephone self-report of drug use in older people and agreement with pharmaceutical claims data. Drugs and Aging 2008; 25(1): 71-80.

9. West SL, Strom BL, Poole CH. Validity of pharmacoepidemiologic drug and diagnostics data. In: Strom BL, ed. Pharmacoepidemiology. West Sussex: John Wiley and Sons Ltd., 2006: 709-67.

10. Nielsen MW, Sondergaard B, Kjoller M, Hansen EH. Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. Journal of Clinical Epidemiology 2008; 61: 919-24.

11. Levy AR, O'Brien BJ, Sellors C, et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Canadian Journal of Clinical Pharmacology 2003; 10(2): 67-71.

12. Zhong H. Equity in pharmaceutical utilization in Ontario: a cross-section and over time analysis. Canadian Public Policy 2007; 33(4): 487-506.

13. Statistics Canada. Bootvar: User Guide (Bootvar 3.1- SAS Version) Ottawa: Statistics Canada, 2005.

14. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall, 1991.

15. Roberts RO, Bergstralh EJ, Schmidt I, Jacobsen SJ. Comparison of self-reported and medical record health care utilisation measures. Journal of Clinical Epidemiology 1996; 49: 989-95.

16. Raina P, Torrance-Rynard V, Wong M, Woodward C. Agreement between self-reported and routinely collected health-care utilization data among seniors. Health Services Research 2002; 37(3): 751-74.

17. Muhajarine N, Mustard C, Roos LL, et al. Comparison of survey and physician claims data for detecting hypertension. Journal of Clinical Epidemiology 1997; 50(6): 711-8.

18. Tu K, Campbell NRC, Chen Z-L, et al. Accuracy of administrative databases in identifying patients with hypertension. Open Medicine 2007; 1(1): E18-26.

19. Johnston DW, Propper C, Shields MA. Comparing subjective and objective measures of health: Evidence from hypertension for the income/health gradient. Journal of Health Economics 2009; 28(3): 540-52.

20. Danon-Hersch N, Marques-Vidal P, Bovet P, et al. Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. European Journal of Cardiovascular Prevention and Rehabilitation 2009; 16(1): 66-72.

21. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. American Journal of Hypertension 2006; 19(11): 1190-6.

22. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. Journal of the American Medical Assoication 2002; 288(4): 462-7.

23. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2008; 2(CD000011):DOI: 10.1002/14651858.CD000011.pub3.

24. Svensson S, Kjellgren KI, Ahlner J, Saljo R. Reasons for adherence with antihypertensive medication. International Journal of Cardiology 2000; 76(2-3): 157-63.

25. Osterberg L, Blaschke T. Adherence to medication. New England Journal of Medicine 2005; 353(5): 487-97.

26. Berk ML, Schur CL, Mohr P. Using survey data to estimate prescription drug costs. Health Affairs 1990; 9(3): 146-56.

27. Anderson JG, Taylor AG. Use of complementary therapies by individuals with or at risk for cardiovascular disease: results of the 2007 National Health Interview Survey. Journal of Cardiovascular Nursing 2012; 27(2): 96-102.

28. Paterson JM, Suleiman A, Hux JE, Bell C. How complete are drug history profiles that are based on public drug benefit claims? Canadian Journal of Clinical Pharmacology 2008; 15(1): e108-16.